IDEAYA Biosciences (IDYA) Insider Trading & Ownership $26.89 +0.11 (+0.41%) (As of 09:07 AM ET) Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends IDEAYA Biosciences (NASDAQ:IDYA) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage3.50%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)3Amount OfInsider Selling(Last 12 Months)$11.86 M Get IDYA Insider Trade Alerts Want to know when executives and insiders are buying or selling IDEAYA Biosciences stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address IDYA Insider Buying and Selling by Quarter Ad Golden CrestBuffett’s Selling Out: Is Your 401(k) About to Get Wiped Out?Let me share something important with you. Just a few weeks ago, Warren Buffett unloaded $932 million worth of bank stocks. He didn't do it on a whim—he knows something big is coming. The question is: Why aren't you taking action, too?Click Here For Your Free Guide IDEAYA Biosciences Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails5/29/2024Michael Anthony WhiteinsiderSell28,500$36.24$1,032,840.00 5/16/2024Yujiro S HataCEOSell34,433$41.81$1,439,643.73 5/14/2024Yujiro S HataCEOSell56,711$41.61$2,359,744.71 2/9/2024Briseno Andres RuizInsiderSell2,000$46.02$92,040.00 2/9/2024Yujiro S HataCEOSell23,557$45.54$1,072,785.78 1/22/2024Briseno Andres RuizInsiderSell2,000$42.03$84,060.00 This Bull Market Indicator called NVDA at $116 (Ad)Every now and again we find an investment idea so incredible we can’t help but share. And today is one of those rare days… Except, today we won't be giving you insight on any one particular stock… But rather, insight on a revolutionary new stock picking indicator… In fact, within the last year, this indicator has become famous for a multitude of reasons… But one of the biggest was because of the buy signal it issued on October 18th, 2022. In fact, on that very day, it said to buy NVDA at $116.37… Anyone who did would be sitting on a tremendously large return today… But even if you missed the original buy signal from October, this incredible indicator issued 11 other buy signals while Nvidia made its epic run…All you have to do is follow this link here1/16/2024Yujiro S HataCEOSell62,739$40.17$2,520,225.63 1/12/2024Briseno Andres RuizInsiderSell2,000$38.01$76,020.00 1/12/2024Yujiro S HataCEOSell12,261$40.04$490,930.44 12/15/2023Yujiro S HataCEOSell75,000$35.03$2,627,250.00 12/14/2023Briseno Andres RuizInsiderSell2,000$34.00$68,000.00 (Data available from 1/1/2013 forward) IDYA Insider Trading Activity - Frequently Asked Questions Who is on IDEAYA Biosciences's Insider Roster? The list of insiders at IDEAYA Biosciences includes Briseno Andres Ruiz, Jason Throne, Michael Anthony White, Paul A Stone, and Yujiro S Hata. Learn more on insiders at IDYA. What percentage of IDEAYA Biosciences stock is owned by insiders? 3.50% of IDEAYA Biosciences stock is owned by insiders. Learn more on IDYA's insider holdings. Which IDEAYA Biosciences insiders have been selling company stock? The following insiders have sold IDYA shares in the last 24 months: Briseno Andres Ruiz ($320,120.00), Jason Throne ($665,620.78), Michael Anthony White ($1,032,840.00), Paul A Stone ($338,904.56), and Yujiro S Hata ($10,510,580.29). How much insider selling is happening at IDEAYA Biosciences? Insiders have sold a total of 339,118 IDEAYA Biosciences shares in the last 24 months for a total of $12,868,065.63 sold. IDEAYA Biosciences Key ExecutivesMr. Yujiro S. Hata (Age 50)President, CEO & Director Compensation: $912kMr. Andres Ruiz Briseno CPA (Age 38)Principal Accounting Officer, Senior VP and Head of Finance & Investor Relations Compensation: $485.12kDr. Michael A. White Ph.D. (Age 58)Chief Scientific Officer Compensation: $661.8kMr. Jason S. Throne Esq. (Age 52)J.D., Chief Legal Officer & Company Secretary Compensation: $598.8kDr. Darrin M. Beaupre M.D. (Age 57)Ph.D., Chief Medical Officer Compensation: $665.58kDr. Paul A. Barsanti Ph.D.Chief Technology OfficerMr. Mick O'QuigleyChief of Staff & Clinical Development More Insider Trading Tools from MarketBeat Related Companies Roivant Sciences Insider Trades Intra-Cellular Therapies Insider Trades Nuvalent Insider Trades Elanco Animal Health Insider Trades Lantheus Insider Trades Blueprint Medicines Insider Trades Cytokinetics Insider Trades Viking Therapeutics Insider Trades Krystal Biotech Insider Trades TG Therapeutics Insider Trades Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Insiders Selling Into 3 Rallies: Investors Should Do the OppositeInsiders Bet Big on These Small Cap StocksHere’s Why Etsy Management Is Investing $1 Billion in BuybacksInsider Buying Signals Upside for These 3 StocksBig Buybacks Announced: 3 Stocks Insiders Are Banking On This page (NASDAQ:IDYA) was last updated on 11/27/2024 by MarketBeat.com Staff From Our PartnersBill Gates’ is about to mint millionaires (again) with Stargate.This little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | Sponsored24/7 Automated Profits in CryptoThe 4th quarter of 2024 is shaping up to be one of the most explosive periods for crypto in recent memory. But...Crypto Swap Profits | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored50-year Wall Street legend: “Sell this tech stock NOW”Something very strange is happening to U.S. stocks following President Trump's victory... And this could s...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding IDEAYA Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share IDEAYA Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free IDYA Stock Alerts